RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 129 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $456,613 | +18.2% | 59,688 | +15.4% | 0.00% | – |
Q2 2023 | $386,311 | -34.7% | 51,715 | -41.7% | 0.00% | – |
Q1 2023 | $591,362 | +8.1% | 88,660 | +24.9% | 0.00% | – |
Q4 2022 | $547,201 | -11.5% | 70,973 | +22.2% | 0.00% | – |
Q3 2022 | $618,000 | +18.2% | 58,070 | -9.7% | 0.00% | – |
Q2 2022 | $523,000 | +11.0% | 64,318 | -2.3% | 0.00% | – |
Q1 2022 | $471,000 | -62.2% | 65,799 | -9.6% | 0.00% | -100.0% |
Q4 2021 | $1,247,000 | +223.9% | 72,801 | +334.3% | 0.00% | – |
Q3 2021 | $385,000 | -19.6% | 16,762 | +27.7% | 0.00% | – |
Q2 2021 | $479,000 | – | 13,122 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kinnevik AB (publ) | 10,405,668 | $77,730,340 | 100.00% |
Data Collective IV GP, LLC | 5,941,120 | $44,380,166 | 32.86% |
MV Management XI, L.L.C. | 1,971,908 | $14,730,153 | 25.77% |
MIC Capital Management UK LLP | 8,451,758 | $63,134,635 | 12.84% |
Yong Rong (HK) Asset Management Ltd | 1,174,200 | $8,772 | 3.85% |
ArchPoint Investors | 1,114,626 | $8,326,256 | 3.22% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,711,148 | $20,252,276 | 0.70% |
HARVARD MANAGEMENT CO INC | 882,129 | $6,590 | 0.65% |
Diametric Capital, LP | 119,906 | $895,698 | 0.40% |
Lingotto Investment Management LLP | 775,077 | $5,789,825 | 0.37% |